4.5 Article

The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: A report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS)

Journal

EUROPEAN NEUROPSYCHOPHARMACOLOGY
Volume 23, Issue 8, Pages 865-871

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.euroneuro.2013.05.004

Keywords

Obsessive compulsive disorder (OCD); Early onset; Duration of illness; Long-term outcome

Funding

  1. National Research Foundation of South Africa (NRF)
  2. Servier
  3. European College of Neuropsycho-pharmacology (ECNP)
  4. UK NHS National Institute of Health Research
  5. UK Medical Research Council
  6. International Society for Addition
  7. ECNP
  8. British Association for Psychopharmacology
  9. Lundbeck
  10. Pfizer
  11. Canadian Foundation for Innovation (CFI)
  12. Forest Laboratories
  13. Janssen-Ortho Inc
  14. National Institutes of Health (NIH)
  15. Pfizer Inc.
  16. Wyeth-Ayerst
  17. Transcept
  18. Roche
  19. Forest
  20. Coronado
  21. Pferin
  22. Abbott
  23. Astra Zeneca
  24. Eli-Lilly
  25. GlaxoSmithKline
  26. Jazz Pharmaceuticals
  27. Johnson Johnson
  28. Orion
  29. Pharmacia
  30. Solvay
  31. Sumitomo
  32. Takeda
  33. Tikvah
  34. Wyeth

Ask authors/readers for more resources

Several studies reported a negative effect of early onset and long duration of illness on long-term outcome in psychiatric disorders, including Obsessive-Compulsive Disorder (OCD). OCD is a prevalent, comorbid and disabling condition, associated with reduced quality of life and overall well-being for affected patients and related caregivers. The present multicenter naturalistic study sought to assess the influence of early onset and duration of illness on long-term outcome in a sample of 376 OCD out-patients worldwide, as part of the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) network. Binary logistic regressions were performed with age at the onset and duration of illness, as continuous independent variables, on a series of different outcome dependent variables, including lifetime number of hospitalizations and suicide attempts, poly-therapy and psychiatric comorbidity. Correlations in terms of disability (SDS) were analyzed as well. Results showed that a longer duration of illness (but not earlier age of onset) was associated with hospitalization (odds ratio=1.03, p=0.01), earlier age at onset with CBT (odds ratio=0.94, p<0.001) and both a later age at onset (odds ratio=1.05, p=0.02) and a shorter duration of illness (odds ratio=0.93, p=0.02) with panic disorder comorbidity. In addition, earlier age at onset inversely correlated with higher social disability (r=-0.12, p=0.048) and longer duration of illness directly correlated with higher disability in work, social and family life (r=0.14, p=0.017; r=0.13, p=0.035; r=0.14, p=0.02). The findings from the present large, multicenter study indicate early onset and long duration of illness as overall negative predictors of long-term outcome in OCD. (C) 2013 Elsevier B.V. and ECNR All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available